Stigma in leprosy: miles to go!

Area of Science:

• Medical Sociology
• Public Health
• Dermatology

Background:

• Leprosy is highly stigmatized, often serving as a metaphor for social exclusion.
• Stigma associated with leprosy is poorly understood and difficult to quantify.
• Stigma reduction is not a priority in current anti-lepropsy programs.

Purpose of the Study:

• To measure the stigma associated with leprosy using the Participation (P) scale.
• To compare participation restriction between patients in a leprosarium and a tertiary care center.
• To identify factors influencing participation restriction in leprosy patients.

Main Methods:

• A comparative, questionnaire-based study involving 60 leprosy patients (30 in each group).
• Patients were interviewed using the Participation (P) scale to assess participation restriction.
• Participation restriction was defined as a P scale score of 13 or higher.

Main Results:

• A significantly higher prevalence of participation restriction was found in the leprosarium group (90%) compared to the tertiary care group (23.3%).
• Mean P scale scores were substantially higher in the leprosarium group (31.9) versus the tertiary care group (8.3).
• Participation restriction correlated positively with disease duration and disability grade, and negatively with education level.

Conclusions:

• Leprosy-associated stigma leads to significant participation restrictions, particularly in institutionalized settings.
• Interventions should focus on early diagnosis of nerve damage and integrated patient-family-community support.
• Addressing stigma requires a multi-level approach involving healthcare providers and community engagement.